Epidemiologic risk profile of human papillomavirus infections in human immunodeficiency virus-positive Chinese women

Japanese Journal of Infectious Diseases

Volumn 64, Issue 5, 2011, Pages 411-416

  Zhang, Yong xi ^a   Xiong, Yan ^a   Gui, Xi En ^a   Chen, Shu Hui ^a   Rong, Yu Ping ^a   Cai, Hong Bin ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEXUAL TRANSMISSION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CD4 LYMPHOCYTE COUNT; CHINA; COHORT STUDIES; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 80053055630     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Castellsagueá, X., Dfá az, M., de Sanjoseá, S., et al. (2006): Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J. Natl. Cancer Inst., 98, 303-315
2. Harper, D.M., Franco, E.L., Wheeler, C., et al. (2004): Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women; a randomized controlled trial. Lancet, 364, 1757-1765.
3. Schiffman, M. and Castle, P.E. (2005): The promise of global cervical-cancer prevention. N. Engl. J. Med., 353, 2101-2104.
4. Strickler, H.D., Burk, R.D., Fazzari, M., et al. (2005): Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J. Natl. Cancer Inst., 97, 577-586.
5. Ministry of Health, People's Republic of China: 2009 Estimates for the HIV/AIDS Epidemic in China. Ministry of Health, People's Republic of China, Joint United Nations Program on HIV/AIDS and World Health Organization. Online at http://www.chinaids.org. Accessed 31 May 2010.
6. Zhang, Y.X., Gui, X.E., Zhong, Y.H., et al. (2010): Cancer in cohort of HIV-infected population: prevalence and clinical characteristics. J. Cancer Res. Clin. Oncol., 137, 609-614.
7. Sawaya, G.F., Chirenje, M.Z., Magure, M.T., et al. (2008): Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial. Obstet. Gynecol., 112, 990-997.
8. Brown, D.R., Shew, M.L., Qadadri, B., et al. (2005): A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J. Infect. Dis., 191, 182-192.
9. Coutleá e, F., Gravitt, P., Kornegay, J., et al. (2002): Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol., 40, 902-907.
10. Cogliano, V., Baan, R., Straif, K., et al. (2005): Carcinogenicity of human papillomaviruses. Lancet Oncol., 6, 204.
11. Tornesello, M.L., Duraturo, M.L., Giorgi-Rossi, P., et al. (2008): Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J. Gen. Virol., 89, 1380-1389.
12. Videla, S., Darwich, L., Canadas, M.P., et al. (2009): Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology. J. Acquired Immune Defic. Syndr., 50, 168-175.
13. Mbulawa, Z.Z., Coetzee, D., Marais, D.J., et al. (2009): Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couple are positively associated with human immunodeficiency virus coinfection. J. Infect. Dis., 199, 1514-1524.
14. Joshi, S.N., Gopalkrishna, V., Kumar, B.K., et al. (2005): Cervical squamous intra-epithelial changes and human papillomavirus infection in women infected with human immunodeficiency virus in Pune, India. J. Med. Virol., 76, 470-475.
15. Yamada, R., Sasagawa, T., Kirumbi, L.W., et al. (2008): Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J. Med. Virol., 80, 847-855.
16. Hagensee, M.E., Cameron, J.E., Leigh, J.E., et al. (2004): Human papillomavirus infection and disease in HIV-infected individuals. Am. J. Med. Sci., 328, 57-63.
17. Clifford, G.M., Goncalves, M.A. and Franceschi, S. (2006): Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS, 20, 2337-2341.
18. Bao, Y.P., Li, N., Smith, J.S. et al. (2008): Human papillomavirus type-distribution in the cervix of Chinese women: a metaanalysis. Int. J. STD AIDS, 19, 106-111.
19. Clifford, G.M., Gallus, S., Herrero, R., et al. (2005): Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV Prevalence Surveys: a pooled analysis. Lancet, 366, 991-998.
20. Didelot-Rousseau, M.N., Nagot, N., Costes-Martineau, V., et al. (2006): Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br. J. Cancer, 95, 355-362.
21. Baay, M.F., Kjetland, E.F., Ndhlovu, P.D., et al. (2004): Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J. Med. Virol., 73, 481-485.
22. Ng'andwe, C., Lowe, J.J., Richards, P.J., et al. (2007): The distribution of sexually-transmitted human papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect. Dis., 7:77.
23. Tsao, K.C., Huang, C.G., Kuo, Y.B., et al. (2010): Prevalence of human papillomavirus genotypes in northern Taiwanese women. J. Med. Virol., 82, 1739-1745.
24. Papachristou, E., Sypsa, V., Paraskevis, D., et al. (2009): Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test. J. Med. Virol., 81, 2059-2065.
25. Strickler, H.D., Palefsky, J.M., Shah, K.V., et al. (2003): Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J. Natl. Cancer Inst., 95, 1062-1071.